Keyword Connections

alzheimer’s disease

Journals

72

1 bioorganic & medicinal chemistry

2 European journal of medicinal chemistry

3 Nature communications

4 Nutrients

5 Scientific reports

6 Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

7 ACS chemical neuroscience

8 Frontiers in pharmacology

9 PloS one

10 Biochemistry

11 Brain research

12 International journal of molecular sciences

13 The Journal of organic chemistry

14 Brain sciences

15 Bioorganic & medicinal chemistry letters

16 BioMed research international

17 BMC Bioinformatics

18 pakistan journal of pharmaceutical sciences

19 European journal of nuclear medicine and molecular imaging

20 journal of clinical medicine

21 neural networks : the official journal of the international neural network society

22 Communications chemistry

23 annals of surgical oncology

24 JAMA

25 Journal of Alzheimer's disease : JAD

26 nature genetics

27 Nature human behaviour

28 annals of surgery

29 Cell reports

30 Biomolecules

31 current opinion in psychology

32 Microbiology resource announcements

33 NeuroImage

34 the lancet psychiatry

35 Journal of speech, language, and hearing research : JSLHR

36 molecular neurobiology

37 Medical education

38 Optics express

39 bioscience, biotechnology, and biochemistry

40 Iranian journal of psychiatry

41 drug development and industrial pharmacy

42 frontiers in molecular neuroscience

43 Alzheimer's research & therapy

44 Aging

45 iranian journal of basic medical sciences

46 ear and hearing

47 journal of cross-cultural gerontology

48 dementia and geriatric cognitive disorders

49 Medical image analysis

50 Pharmaceutical research

51 Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

52 facial plastic surgery : fps

53 frontiers in cellular neuroscience

54 current alzheimer research

55 Molecular and cellular biochemistry

56 the journal of higher education

57 the american journal of psychiatry

58 archives of environmental contamination and toxicology

59 reviews in the neurosciences

60 JAMA neurology

61 the permanente journal

62 HPB : the official journal of the International Hepato Pancreato Biliary Association

63 journal of market access & health policy

64 journal of cerebral blood flow and metabolism : official journal of the international society of cerebral blood flow and metabolism

65 archives of clinical neuropsychology : the official journal of the national academy of neuropsychologists

66 ieee access : practical innovations, open solutions

67 The journal of prevention of Alzheimer's disease

68 journal of drug targeting

69 bioRxiv : the preprint server for biology

70 Med (New York, N.Y.)

71 Mymensingh medical journal : MMJ

72 Brain communications

Research Groups

0

No Research Group Connected

Bibliographies

311

1 Impact of Anti-Dementia Medication on the Risk of Death and Causes of Death in Alzheimer's Disease.

2 Enhancement of tripartite synapses as a potential therapeutic strategy for Alzheimer's disease: a preclinical study in rTg4510 mice.

3 Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis.

4 Restoration of Olfactory Memory in Overexpressing Human Alzheimer's Disease Associated Tau by Manipulation of L-Type Ca Channels.

5 Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease.

6 Economic burden for Alzheimer's disease in China from 2010 to 2050: a modelling study.

7 Recognition of Famous and Unfamiliar Faces among Patients Suffering from Amnesia Mild Cognitive Impairment (AMCI) and Alzheimer's Disease.

8 Age-differential relationships among dopamine D1 binding potential, fusiform BOLD signal, and face-recognition performance.

9 Detection and Attention for Auditory, Visual, and Audiovisual Speech in Children with Hearing Loss.

10 Neural dynamics of racial categorization predicts racial bias in face recognition and altruism.

11 Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.

12 Perspectives on ICD-11 to understand and improve mental health diagnosis using expertise by experience (INCLUDE Study): an international qualitative study.

13 Mixed-Location Cerebral Microbleeds: An Imaging Biomarker for Cerebrovascular Pathology in Cognitive Impairment and Dementia in a Memory Clinic Population.

14 Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer's Disease.

15 Coping Strategies Utilized by Middle-Aged and Older Latino Caregivers of Loved Ones with Alzheimer's Disease and Related Dementia.

16 BIN1 rs744373 variant shows different association with Alzheimer's disease in Caucasian and Asian populations.

17 APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain.

18 Mercury and Alzheimer's Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization.

19 A novel multi-modal machine learning based approach for automatic classification of EEG recordings in dementia.

20 Potential application of Aloe Vera-derived plant-based cell in powering wireless device for remote sensor activation.

21 Seeing pressure in color based on integration of highly sensitive pressure sensor and emission tunable light emitting diode.

22 Electrochemical micro analytical device interfaced with portable potentiostat for rapid detection of chlorpyrifos using acetylcholinesterase conjugated metal organic framework using Internet of things.

23 Toward self-powered and reliable visible light communication using amorphous silicon thin-film solar cells.

24 Comprehension of written texts for the assessment of clinical competence and decision making in people with mild to moderate Alzheimer disease.

25 Quality of life in people with dementia living in nursing homes: validation of an eight-item version of the QUALIDEM for intensive longitudinal assessment.

26 Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.

27 Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease.

28 Intravascular Large B-cell Lymphoma Associated with Systemic and Central Nervous System Hemophagocytic Lymphohistiocytosis: A Case Report.

29 Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.

30 Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.

31 Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study.

32 Safe implementation of minimally invasive pancreas resection: a systematic review.

33 Lifestyle Factors and Subjective Cognitive Impairment in Patients Seeking Help at a Memory Disorder Clinic: The Role of Negative Life Events.

34 Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease1,2.

35 Selected microRNAs Increase Synaptic Resilience to the Damaging Binding of the Alzheimer's Disease Amyloid Beta Oligomers.

36 MCADNNet: Recognizing Stages of Cognitive Impairment through Efficient Convolutional fMRI and MRI Neural Network Topology Models.

37 Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer's disease spectrum.

38 Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern.

39 Diurnal Cortisol Dynamics, Perceived Stress, and Language Production in Aphasia.

40 High occurrence of transportation and logistics occupations among vascular dementia patients: an observational study.

41 Confabulations on Time: Relationship between Confabulations and Timing Deviations in Alzheimer's Disease.

42 1-(2',5'-Dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1-propanone (RGM079): A Positive Allosteric Modulator of α7 Nicotinic Receptors with Analgesic and Neuroprotective Activity.

43 Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters.

44 Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study.

45 The Val66Met Polymorphism Modulates Resilience of Neurological Functioning to Brain Ageing and Dementia: A Narrative Review.

46 Synaptic plasticity in Alzheimer's disease and healthy aging.

47 Repeatability of parametric methods for [F]florbetapir imaging in Alzheimer's disease and healthy controls: A test-retest study.

48 Global Mapping of Interventions to Improve Quality of Life of Patients with Alzheimer's Disease during 1990-2018.

49 A Deep Siamese Convolution Neural Network for Multi-Class Classification of Alzheimer Disease.

50 Dual functional liposomes carrying antioxidants against tau hyperphosphorylation and apoptosis of neurons.

51 Risk Factors for Alzheimer's Disease: Focus on Stress.

52 Estimating the potential for dementia prevention through modifiable risk factors elimination in the real-world setting: a population-based study.

53 Emphasis Learning, Features Repetition in Width Instead of Length to Improve Classification Performance: Case Study—Alzheimer’s Disease Diagnosis

54 Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease.

55 The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.

56 Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease.

57 Hepatoprotective and neuroprotective flavanes from the fruits of Ulmus pumila L. (Ulmaceae).

58 The development of 2-acetylphenol-donepezil hybrids as multifunctional agents for the treatment of Alzheimer's disease.

59 Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease.

60 Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease.

61 Cobalt/Copper-Cocatalyzed Synthesis of Imidazo[1,2-a:3,4-a']dipyridiniums from 2H-[1,2'-Bipyridin]-2-ones and 2-Bromoacetophenones.

62 the role of micrornas in aβ deposition and tau phosphorylation in alzheimer’s disease

63 resting state bold variability in alzheimer’s disease: a marker of cognitive decline or cerebrovascular status?

64 amyloid β1-42 (aβ1-42) induces the cdk2-mediated phosphorylation of tau through the activation of the mtorc1 signaling pathway while promoting neuronal cell death

65 bace1 inhibitor mk-8931 alters formation but not stability of dendritic spines

66 probing the origins of human acetylcholinesterase inhibition via qsar modeling and molecular docking

67 altered behavioral and autonomic pain responses in alzheimer’s disease are associated with dysfunctional affective, self-reflective and salience network resting-state connectivity

68 amaryllidaceae alkaloids of belladine-type from <i>narcissus pseudonarcissus</i> cv. carlton as new selective inhibitors of butyrylcholinesterase

69 cerebrospinal fluid p-tau181p: biomarker for improved differential dementia diagnosis

70 back to the fusion: mitofusin-2 in alzheimer’s disease

71 lewy body variant of alzheimer disease

72 cerebrovascular-reactivity mapping using mri: considerations for alzheimer’s disease

73 oligomeric amyloid-β peptide on sialylic lewisx–selectin bonding at cerebral endothelial surface

74 clinical features and experimental models of cerebral small vessel disease

75 predicting cerebral amyloid angiopathy-realated intracerebral hemorrhages and other cerebrovascular disorders in alzheimer’s disease

76 analyzing nicotinamide adenine dinucleotide phosphate oxidase activation in aging and vascular amyloid pathology

77 protein phosphorylation in neurodegeneration: friend or foe?

78 effective artifact removal in resting state fmri data improves detection of dmn functional connectivity alteration in alzheimer’s disease

79 insulin resistance and alzheimer’s disease: bioenergetic linkages

80 Overcoming Alzheimer's Disease Stigma by Leveraging Artificial Intelligence and Blockchain Technologies.

81 a peephole into the brain: neuropathological features of alzheimer’s disease revealed by in vivo two-photon imaging

82 index of alpha/theta ratio of the electroencephalogram: a new marker for alzheimer’s disease

83 benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to alzheimer’s disease patients

84 differential roles of environmental enrichment in alzheimer’s type of neurodegeneration and physiological aging

85 β-secretase 1´s targeting reduces hyperphosphorilated tau, implying autophagy actors in 3xtg-ad mice

86 somatostatinergic systems: an update on brain functions in normal and pathological aging

87 alzheimer’s transgenic model is characterized by very early brain network alterations and β-ctf fragment accumulation: reversal by β-secretase inhibition

88 evaluation of the amyloid beta-gfp fusion protein as a model of amyloid beta peptides-mediated aggregation: a study of dnajb6 chaperone

89 long and short-term cdk5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic alzheimer´s mice

90 anti-amyloid aggregation activity of black sesame pigment: toward a novel alzheimer’s disease preventive agent

91 exploring patterns of alteration in alzheimer’s disease brain networks: a combined structural and functional connectomics analysis

92 monoacylated cellular prion proteins reduce amyloid-β-induced activation of cytoplasmic phospholipase a2 and synapse damage

93 molecular mechanism of the intramembrane cleavage of the β-carboxyl terminal fragment of amyloid precursor protein by γ-secretase

94 deciphering the astrocyte reaction in alzheimer’s disease

95 curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of alzheimer’s disease

96 bace1 rnai restores the composition of phosphatidylethanolamine-derivates related to memory improvement in aged 3xtg-ad mice

97 novel autoimmune response in a tauopathy mouse model

98 effect of mindfulness program on caregivers’ strain on alzheimer’s disease caregivers

99 Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review.

100 cilostazol suppresses aβ-induced neurotoxicity in sh-sy5y cells through inhibition of oxidative stress and mapk signaling pathway

101 the role of micrornas in alzheimer’s disease and their therapeutic potentials